FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2798130906> ?p ?o ?g. }

• W2798130906 endingPage "e4578" @default.
• W2798130906 startingPage "e4578" @default.
• W2798130906 abstract "Background Cardiovascular disease is a major cause of mortality and morbidity in people with type 2 diabetes mellitus (T2DM). Studies have consistently identified dyslipidemia as an important risk factor for the development of macrovascular disease. The landmark United Kingdom Prospective Diabetes Study has shown that metformin therapy reduces cardiovascular events in overweight people with T2DM. This study investigates the effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed T2DM, and whether the effect, if any, is dosage-related. Methods This cohort study enrolled individuals exceeding 20 years of age, with recent onset T2DM, who received at least 12 months of metformin monotherapy and blood tests for serum lipid at 6-month intervals. Exclusion criteria involved people receiving any additional antidiabetic medication or lipid-lowering drug therapy. Lipid-modifying effect of metformin was recorded as levels of serum triglycerides (TG), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) measured at six month intervals. Results The study enrolled 155 participants with a mean age of 58.6 years and average glycosylated hemoglobin A 1c of 8%. After initiating metformin therapy, LDL-C was significantly reduced from 111 mg/dl to 102 mg/dL at 6 months ( P < 0.001), TG was reduced from 132 mg/dl to 122 mg/dL at 12 months ( P = 0.046), and HDL-C increased from 45.1 mg/dL to 46.9 mg/dL at 12 months ( P = 0.02). However, increasing the dosage of metformin yielded no significant effect on its lipid-lowering efficacy. Discussion Metformin monotherapy appreciably improves dyslipidemia in statin-naive people with T2DM. Its lipid-modifying effect may be attributable to insulin sensitization, reduction of irreversibly glycated LDL-C, and weight loss. In practice, people with dyslipidemia who are ineligible for lipid-lowering agents may benefit from metformin therapy. Moreover, previous studies report a synergistic effect between metformin and statin, which may further reduce cardiovascular events in at-risk individuals. Overall, metformin is a safe and efficacious approach to alleviate dyslipidemia in people with newly diagnosed T2DM." @default.
• W2798130906 created "2018-04-24" @default.
• W2798130906 creator A5049918509 @default.
• W2798130906 creator A5052474637 @default.
• W2798130906 creator A5059076446 @default.
• W2798130906 creator A5074833626 @default.
• W2798130906 creator A5089113107 @default.
• W2798130906 creator A5090056119 @default.
• W2798130906 date "2018-04-12" @default.
• W2798130906 modified "2023-10-16" @default.
• W2798130906 title "Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study" @default.
• W2798130906 cites W1824516519 @default.
• W2798130906 cites W1965780112 @default.
• W2798130906 cites W1966884669 @default.
• W2798130906 cites W1987981915 @default.
• W2798130906 cites W1994096988 @default.
• W2798130906 cites W2014895867 @default.
• W2798130906 cites W2017421207 @default.
• W2798130906 cites W2065827854 @default.
• W2798130906 cites W2070692648 @default.
• W2798130906 cites W2071133398 @default.
• W2798130906 cites W2075550098 @default.
• W2798130906 cites W2095521683 @default.
• W2798130906 cites W2096559770 @default.
• W2798130906 cites W2104502364 @default.
• W2798130906 cites W2107295258 @default.
• W2798130906 cites W2110798021 @default.
• W2798130906 cites W2140429097 @default.
• W2798130906 cites W2154024364 @default.
• W2798130906 cites W2243802007 @default.
• W2798130906 cites W2255443535 @default.
• W2798130906 cites W2255457724 @default.
• W2798130906 cites W2299831368 @default.
• W2798130906 cites W2345368448 @default.
• W2798130906 cites W2581706353 @default.
• W2798130906 cites W3187443279 @default.
• W2798130906 cites W4235257895 @default.
• W2798130906 cites W4239837977 @default.
• W2798130906 cites W4252437054 @default.
• W2798130906 doi "https://doi.org/10.7717/peerj.4578" @default.
• W2798130906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5899882" @default.
• W2798130906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29666753" @default.
• W2798130906 hasPublicationYear "2018" @default.
• W2798130906 type Work @default.
• W2798130906 sameAs 2798130906 @default.
• W2798130906 citedByCount "43" @default.
• W2798130906 countsByYear W27981309062019 @default.
• W2798130906 countsByYear W27981309062020 @default.
• W2798130906 countsByYear W27981309062021 @default.
• W2798130906 countsByYear W27981309062022 @default.
• W2798130906 countsByYear W27981309062023 @default.
• W2798130906 crossrefType "journal-article" @default.
• W2798130906 hasAuthorship W2798130906A5049918509 @default.
• W2798130906 hasAuthorship W2798130906A5052474637 @default.
• W2798130906 hasAuthorship W2798130906A5059076446 @default.
• W2798130906 hasAuthorship W2798130906A5074833626 @default.
• W2798130906 hasAuthorship W2798130906A5089113107 @default.
• W2798130906 hasAuthorship W2798130906A5090056119 @default.
• W2798130906 hasBestOaLocation W27981309061 @default.
• W2798130906 hasConcept C126322002 @default.
• W2798130906 hasConcept C134018914 @default.
• W2798130906 hasConcept C188816634 @default.
• W2798130906 hasConcept C2776839432 @default.
• W2798130906 hasConcept C2777180221 @default.
• W2798130906 hasConcept C2778096610 @default.
• W2798130906 hasConcept C2778163477 @default.
• W2798130906 hasConcept C2778270857 @default.
• W2798130906 hasConcept C2780323712 @default.
• W2798130906 hasConcept C2780920962 @default.
• W2798130906 hasConcept C2910068830 @default.
• W2798130906 hasConcept C555293320 @default.
• W2798130906 hasConcept C71924100 @default.
• W2798130906 hasConcept C72563966 @default.
• W2798130906 hasConcept C90924648 @default.
• W2798130906 hasConceptScore W2798130906C126322002 @default.
• W2798130906 hasConceptScore W2798130906C134018914 @default.
• W2798130906 hasConceptScore W2798130906C188816634 @default.
• W2798130906 hasConceptScore W2798130906C2776839432 @default.
• W2798130906 hasConceptScore W2798130906C2777180221 @default.
• W2798130906 hasConceptScore W2798130906C2778096610 @default.
• W2798130906 hasConceptScore W2798130906C2778163477 @default.
• W2798130906 hasConceptScore W2798130906C2778270857 @default.
• W2798130906 hasConceptScore W2798130906C2780323712 @default.
• W2798130906 hasConceptScore W2798130906C2780920962 @default.
• W2798130906 hasConceptScore W2798130906C2910068830 @default.
• W2798130906 hasConceptScore W2798130906C555293320 @default.
• W2798130906 hasConceptScore W2798130906C71924100 @default.
• W2798130906 hasConceptScore W2798130906C72563966 @default.
• W2798130906 hasConceptScore W2798130906C90924648 @default.
• W2798130906 hasLocation W27981309061 @default.
• W2798130906 hasLocation W27981309062 @default.
• W2798130906 hasLocation W27981309063 @default.
• W2798130906 hasLocation W27981309064 @default.
• W2798130906 hasLocation W27981309065 @default.
• W2798130906 hasOpenAccess W2798130906 @default.
• W2798130906 hasPrimaryLocation W27981309061 @default.
• W2798130906 hasRelatedWork W2020213380 @default.
• W2798130906 hasRelatedWork W2136047525 @default.

• next